News

Learn more about Advarra's new Gene Therapy Ready Site Network.

YourEncore significantly expands Advarra’s consulting capabilities to address mission-critical challenges for the biopharmaceutical industry

The exception is the IntegReview IRB office in Austin, Texas, which will be closed Thursday, December 24, and Friday, December 25.

Advarra, the market leader in regulatory review solutions and clinical site technologies, announced today that it has named Steven Buonaiuto to the position of Chief Financial Officer (CFO).

Advarra Acquires Longboat, a Leading Provider of Site Training, Protocol Compliance, and Patient Engagement Solutions

On October 23, 2020, the US Department of Health and Human Services Office of the General Counsel (HHS OGC) issued two important Advisory Opinions, 20-03 and 20-04, about the Public Readiness and Emergency Preparedness (PREP) Act and the HHS Secretary’s March 10, 2020, Declaration under the PREP Act for medical countermeasures against COVID-19.

Advarra acquires IntegReview IRB, an AAHRPP-accredited central IRB.

On November 10, Advarra Vice President of Research Services and Strategic Consulting James Riddle will be a guest speaker at the Georgia State University Ethics Awareness Week.

This week, Advarra will release an update to the Center for IRB Intelligence (CIRBI®) Platform, continuing our focus of accelerating user workflows while ensuring the highest quality IRB reviews available.

Signant Health recently initiated the #NoGoingBack movement, recognizing that COVID-19 forced the clinical research community to move trial conduct forward rapidly.

Advarra Director of Biosafety Services joins other biosafety experts in describing proper protocols to follow when handling infectious materials in the lab.

Advarra announced the appointment of Scott Uebele as president & chief research services officer, effective October 2, 2020.